资讯 | 中国进入5G商用时代,5G概念集体高走

wechat omage

美股

北京时间11月2日凌晨,美股周五收高,道指上涨300点,纳指与标普500指数创历史最高收盘纪录。美国10月非农就业人数增加12.8万超出预期,失业率为3.6%仍处在50年来的最低水平。市场仍关注国际贸易关系的进展与美企财报。

截止收盘,道指收盘上涨301.13点,或1.11%,报27347.36点;标普500指数涨29.35点,或0.97%,报3066.91点;纳指涨94.04点,或1.13%,报8386.40点。

道指成份公司当中,卡特彼勒(144.49, 6.69, 4.85%)(CAT)、沃尔格林(57.38, 2.60, 4.75%)联合博姿集团(WBA)、陶氏(52.31, 1.82, 3.60%)化学(DOW)、明尼苏达矿业制造(170.09, 5.10, 3.09%)(MMM)、埃克森美孚(69.6, 2.03, 3.00%)(XOM)、苹果(255.82, 7.06, 2.84%)(AAPL)、摩根大通(127.8, 2.88, 2.31%)(JPM)、迪士尼(132.75, 2.83, 2.18%)(DIS)、联合技术(146.68, 3.10, 2.16%)(UTX)等涨幅领先。

美联储今年已经连续三次降息,每次下调利率25个基点。

周五美企财报继续集中出炉。埃克森美孚公司(XOM)宣布盈利超出预期。美国钢铁公司(X)季度亏损额低于预期。Qorvo业绩超出预期,同时发布了强劲的业绩报告。

迄今为止,约有70%的标普500成份公司公布了财报,其中75%的盈利超出预期。

宏观基本面:

美国劳工部周五报告称,美国10月非农就业人口增加12.8万,预期8.5万。9月非农就业人数从原先公布的13.6万修正为18万。8月和9月非农就业人数总共上修了9.5万。

非农就业数据还显示,10月失业率为3.6%,预期3.6%,前值3.5%。10月劳动力参与率为63.3%,预期63.1%,前值63.2%。

10月平均每周工时为34.4小时,预期34.4小时,前值34.4小时。平均时薪环比增长0.2%,预期0.3%,前值0%。10月平均时薪同比增长3%,预期3%,前值从2.9%修正为3.0%。

美国10月私营部门就业人数增加13.1万,预期8万人,前值从11.4万修正为16.7万人。10月制造业就业人数减少3.6万人,预期减少5.5万人,前值减少0.2万人。

美国劳工部表示,过去三个月,每月平均新增非农就业人数为17.6万。10月食品行业、社会救助以及金融活动就业人数录得显著增加。制造业内的汽车车辆及零部件生产行业就业人数因罢工减少4.2万。
焦点个股:

美国医药巨头安进宣布,将以约27亿美元现金或美国存托股每股174.85美元,购入百济神州20.5%股份。这一价格溢价36%。

阿里巴巴第二财季总营收1190.2亿元,市场预期1168亿元,去年同期851.5亿元。

道指成份股埃克森美孚(XOM)第三财季总营收为650.49亿美元,市场预期为647.89亿美元,去年同期为766.05亿美元。

制药商AbbVie(ABBV)宣布盈利与营收超出预期,同时上调了全年业绩目标,并将股息上调10%。

Newell Brands(NWL)第三财季盈利与销售收入均超出预期,并上调全年盈利与销售收入目标。

汽车租赁企业Avis Budget Group(CAR)股价大幅下跌,该公司经过调整后的第三财季盈利远逊市场预期。

 

   

港股

北京时间11月1日,周四美国三大股指集体收跌,道指跌逾140点,纳指收跌0.14%。美众院通过弹劾总统调查程序。苹果逆市涨超2%,Facebook涨1.8%,因财报好于预期。卡夫亨氏盈利超预期,股价涨逾13%,创史上最大单日涨幅。10月,道指涨0.48%,纳指涨3.66%,标普500指数涨2.04%。周五早盘,恒指低开高走

截至收盘,恒生指数涨0.72%,报27100.76点,收盘创9月16日以来新高。国企指数涨0.85%。红筹指数涨1.27%。

热点板块:

5G概念股集体走高,其中,长飞光纤光缆涨11.97%,京信通信涨8.29%,中兴通讯涨3.18%。工信部王志勤称,明年将会是5G基站大规模建设期。2019年中国国际信息通信展览会开幕式上,工信部与三大运营商、中国铁塔(1.78, 0.05, 2.89%)联合举行了5G商用启动仪式,宣布中国5G大规模商用正式开启。中国信息通信研究院副院长王志勤表示,5G基站建设投资较大,一般都是分批开展建设。根据有关规划,年内将在50个城市建13万个5G基站。预计明年将会是5G基站大规模建设期,相信会逐步部署到全国各个城市。此外,中国移动、中国联通、中国电信正式公布5G套餐,并于11月1日正式上线5G商用套餐。这标志着我国将正式进入5G商用时代。

医药股走势分化,其中,百济神州涨31.89%,信达生物涨1.88%。目前港股市场医疗保健业股票资金净主动买入最多。美国生物制药巨头安进药品(Amgen)宣布购入中国备受瞩目的创新生物药企百济神州逾五分之一股权。该交易旨在帮助公司扩大在中国这一全球第二大药品市场的份额。根据一份公开声明,安进药品将以27亿美元现金,或美国存托股(ADS)每股174.85美元的价格,收购百济神州20.5%的股权。这一交易价格较百济神州截至10月30日在纳斯达克股票市场上30天交易量加权平均价相比溢价36%。迄今为止,这笔交易是国际生物制药企业和中国药企之间金额最大、涉及产品线最多的交易,也是全球生物制药领域金额最大的一次股权投资。

 

中国A股

北京时间11月1日,受外盘市场影响,三大股指早盘小幅低开随后悉数翻红,呈深强沪弱格局。临近上午收盘,指数翻红后盘整后再度上攻,深成指涨幅超过1%,上证50指数涨势喜人。午后,三大股指继续走强,上证50、沪深300指数涨逾1.5%。尾盘,三大指数稍显回落但仍旧维持高位,无线耳机科技股持续拉升。总体上,市场氛围持续回暖,赚钱效应转好,股指在相应的技术层面也有所修复。

截止收盘,沪指报2958.20点,涨0.99%,深成指报9802.33点,涨1.73%。

从盘面上看,家电、稀土、白马股居板块涨幅榜前列,养殖业、乳业、动物疫苗板块跌幅榜前列。

热点板块:

家电行业走强,康盛股份涨停,海尔智家、华帝股份、格力电器、飞科电器、美的集团等个股集体走高。

消息面上“双十一”前资本市场再预热,此前国金证券(8.580, 0.07, 0.82%)发表报告指,从各个品类双十一预售情况看,美的在营销推广上收到了较好效果,几乎所有品类的市场份额均有所提高。分领域来看,在龙头优势更为明显的冰洗领域,海尔、美的两强垄断的趋势更加明显,苏泊尔(79.210, 4.58, 6.14%)则在厨电、生活电器板块延续了过去一年的增长趋势。

 
如果有想了解更多全球股市资讯,请关注微信公众号 “辉立资本新加坡” (SGPSPL)

同时提供在线免费开设股票账户,一个账户轻松交易美股,港股,新加坡股,中国A股,越南股票,韩国股票,德国股票,马来西亚股票,泰国股票,印尼股票,菲律宾股票,日本股票,澳大利亚股票,台湾股票,加拿大股票,英国股票,法国股票,荷兰股票,葡萄牙股票,比利时股票,土耳其股票
 

来源:东方财富网,新浪财经,同花顺,21世纪经济报道,彭博,华尔街见闻,辉立证券

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com